Ardonagh Community Trust Awards Muscular Dystrophy Ireland €5,000
Ardonagh Community Trust awards Muscular Dystrophy Ireland €5,000 as part of their community grant scheme.
Reimbursement Approval of Evrysdi® for the Treatment of Spinal Muscular Atrophy
On 1 September the HSE announced that Risdiplam (Evrysdi®) has been approved for reimbursement in Ireland. This makes Risdiplam the third SMA medicine available in Ireland, alongside Zolgensma and Spinraza.